189 related articles for article (PubMed ID: 30808842)
1. Immunoregulatory Effects of Neuropeptides on Endothelial Cells: Relevance to Dermatological Disorders.
Mehta D; Granstein RD
Dermatology; 2019; 235(3):175-186. PubMed ID: 30808842
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems.
Scholzen T; Armstrong CA; Bunnett NW; Luger TA; Olerud JE; Ansel JC
Exp Dermatol; 1998; 7(2-3):81-96. PubMed ID: 9583747
[TBL] [Abstract][Full Text] [Related]
3. Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice.
Németh J; Reglödi D; Pozsgai G; Szabó A; Elekes K; Pintér E; Szolcsányi J; Helyes Z
Neuroscience; 2006 Nov; 143(1):223-30. PubMed ID: 16938409
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptides in the skin of patients with atopic dermatitis.
Ostlere LS; Cowen T; Rustin MH
Clin Exp Dermatol; 1995 Nov; 20(6):462-7. PubMed ID: 8857337
[TBL] [Abstract][Full Text] [Related]
5. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema.
Järvikallio A; Harvima IT; Naukkarinen A
Arch Dermatol Res; 2003 Apr; 295(1):2-7. PubMed ID: 12709813
[TBL] [Abstract][Full Text] [Related]
6. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes.
Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S
Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178
[TBL] [Abstract][Full Text] [Related]
7. Neuromediators--a crucial component of the skin immune system.
Luger TA
J Dermatol Sci; 2002 Nov; 30(2):87-93. PubMed ID: 12413763
[TBL] [Abstract][Full Text] [Related]
8. Neurotransmitters, neuropeptides and their receptors interact with immune response in healthy and psoriatic skin.
Sandoval-Talamantes AK; Gómez-González BA; Uriarte-Mayorga DF; Martínez-Guzman MA; Wheber-Hidalgo KA; Alvarado-Navarro A
Neuropeptides; 2020 Feb; 79():102004. PubMed ID: 31902596
[TBL] [Abstract][Full Text] [Related]
9. Migraine and neuropeptides.
Tajti J; Szok D; Majláth Z; Tuka B; Csáti A; Vécsei L
Neuropeptides; 2015 Aug; 52():19-30. PubMed ID: 26094101
[TBL] [Abstract][Full Text] [Related]
10. Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model.
Roggenkamp D; Köpnick S; Stäb F; Wenck H; Schmelz M; Neufang G
J Invest Dermatol; 2013 Jun; 133(6):1620-8. PubMed ID: 23283070
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study.
Pincelli C; Fantini F; Massimi P; Girolomoni G; Seidenari S; Giannetti A
Br J Dermatol; 1990 Jun; 122(6):745-50. PubMed ID: 1695105
[TBL] [Abstract][Full Text] [Related]
12. Patients with lower motor spinal cord lesion: a decrease of vasoactive intestinal polypeptide, calcitonin gene-related peptide and substance P, but not neuropeptide Y and somatostatin-immunoreactive nerves in the detrusor muscle of the bladder.
Crowe R; Moss HE; Chapple CR; Light JK; Burnstock G
J Urol; 1991 Mar; 145(3):600-4. PubMed ID: 1705295
[TBL] [Abstract][Full Text] [Related]
13. Peptide-immunoreactive neurons and nerve fibres in lumbosacral sympathetic ganglia: selective elimination of a pathway-specific expression of immunoreactivities following sciatic nerve resection in kittens.
Lindh B; Risling M; Remahl S; Terenius L; Hökfelt T
Neuroscience; 1993 Jul; 55(2):545-62. PubMed ID: 7690913
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms of Neurogenic Inflammation of the Skin.
Marek-Jozefowicz L; Nedoszytko B; Grochocka M; Żmijewski MA; Czajkowski R; Cubała WJ; Slominski AT
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902434
[TBL] [Abstract][Full Text] [Related]
15. Increased number of immunoreactive nerve fibers in atopic dermatitis.
Tobin D; Nabarro G; Baart de la Faille H; van Vloten WA; van der Putte SC; Schuurman HJ
J Allergy Clin Immunol; 1992 Oct; 90(4 Pt 1):613-22. PubMed ID: 1383306
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells.
Odum L; Petersen LJ; Skov PS; Ebskov LB
Inflamm Res; 1998 Dec; 47(12):488-92. PubMed ID: 9892043
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase-activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammation.
Mulder H; Jongsma H; Zhang Y; Gebre-Medhin S; Sundler F; Danielsen N
Mol Neurobiol; 1999 Jun; 19(3):229-53. PubMed ID: 10495105
[TBL] [Abstract][Full Text] [Related]
18. The co-localization of neuropeptides in the submucosa of the small intestine of normal Wistar and non-diabetic BB rats.
Pataky DM; Curtis SB; Buchan AM
Neuroscience; 1990; 36(1):247-54. PubMed ID: 1699158
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptides in lower urinary tract function.
Arms L; Vizzard MA
Handb Exp Pharmacol; 2011; (202):395-423. PubMed ID: 21290237
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence.
Moller K; Zhang YZ; Håkanson R; Luts A; Sjölund B; Uddman R; Sundler F
Neuroscience; 1993 Dec; 57(3):725-32. PubMed ID: 7508577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
